1990
DOI: 10.1007/978-1-4684-5730-8_27
|View full text |Cite
|
Sign up to set email alerts
|

Selenium and Oxidant Injury in Patients with Cystic Fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
4
0

Year Published

1995
1995
2019
2019

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 7 publications
1
4
0
Order By: Relevance
“…This is despite mean plasma levels of vitamins A and E within the laboratory normal range and a clinic policy of multivitamin supplementation, with vitamins A and E supplements for patients known to have low-plasma vitamin A and/or E. This finding is consistent with other reports (2,(5)(6)(7)(8)(9) and confirms that lipid peroxidation is increased in CF using a reliable in vivo marker of oxidative stress. The 8-iso-PGF 2α levels for the 12 subjects with CF ≥ 14 yr of age were elevated when compared with the controls (P = 0.038).…”
Section: Discussionsupporting
confidence: 90%
“…This is despite mean plasma levels of vitamins A and E within the laboratory normal range and a clinic policy of multivitamin supplementation, with vitamins A and E supplements for patients known to have low-plasma vitamin A and/or E. This finding is consistent with other reports (2,(5)(6)(7)(8)(9) and confirms that lipid peroxidation is increased in CF using a reliable in vivo marker of oxidative stress. The 8-iso-PGF 2α levels for the 12 subjects with CF ≥ 14 yr of age were elevated when compared with the controls (P = 0.038).…”
Section: Discussionsupporting
confidence: 90%
“…10,11) Changes less remarkable than our results have been reported in patients with a variety of disorders, in which somewhat low plasma concentrations of Se have been associated with higher plasma concentrations of zinc and iron and a lower concentration of copper compared with healthy controls. [17][18][19] Therefore it is possible to note that Se is not an exceptional element in the generally-held recognition that the use and metabolism of mineral nutrients are closely interrelated with each other.…”
Section: Discussionmentioning
confidence: 99%
“…In plasma and RBC (Neve, et al, 1983a) 20 7-19 In plasma and RBC (Neve, et al, 1983b) 14 2-19 In plasma (Richard, et al, 1990) 13 6-15 In plasma (van Caillie-Bertrand, et al, 1982) 20 19-34 In serum (Stead, et al, 1985) 31 3-35 In serum (Michalke, 2004) 15 0-14 − (Ward, et al, 1984) No difference 27 7-20 In plasma (Portal, et al, 1993) Decreased GPX levels 14 2-19 In plasma and RBC (Richard, et al, 1990) 6 − Very low levels in untreated children (Foucaud, et al, 1988) 20 − Mild deficiency in children with pancreatic enzyme replacement (Foucaud, et al, 1988) 15 0-14 Significant decrease in children below the age of 6 (Ward, et al, 1984) No difference 13 10-22 − (Percival, et al, 1995) Se levels in other analytes − 1-18 Decreased Se levels in hair of CF patient from Stavropol region, Russia (Dworkin, et al, 1987) Zinc (Zn)…”
Section: -19mentioning
confidence: 99%
“…Decreased levels 40 1-46 In plasma of 10% of CF patients (Akanli, et al, 2003) 15 Mean 1.8 months In plasma of 30% of CF patients (Krebs, et al, 2000) 27 3 months-12 years In 96% of North Indian CF children (Yadav, et al, 2014) 304 18-66 In plasma of 22% of patients with moderate lung disease (Damphousse, et al, 2014) 13 2-19 In plasma (Safai-Kutti, et al, 1991) 20 7-19 In plasma of patients with moderate-severe growth retardation and severe pulmonary disease (Neve, et al, 1983b) 14 2-19 In serum (Richard, et al, 1990) 51 1-46 In RBC of 31% of CF patients (Akanli, et al, 2003) Elevated levels 20 7-19 In RBC (Neve, et al, 1983a) 20 7-19 In RBC (Neve, et al, 1983b) No difference 18 6-17 In plasma, decreases with age (Jacob, et al, 1978) 20 7-19 In plasma of relatively healthy CF patients (Neve, et al, 1983b) 15…”
Section: -19mentioning
confidence: 99%
See 1 more Smart Citation